This work is in line with recent papers demonstrating convergent evolutionary trajectories in murine and human pancreatic cancers, where the spontaneous loss of CDKN2A/B, TP53 and SMAD4 represents a constrained route to malignant progression30,31. This evidence concerns the gene CDKN2A and familial pancreatic carcinoma.